Promentis Pharmaceuticals
promentispharma.comLocations
United States · Milwaukee, WI, USA · South Milwaukee, WI, USA
industry
Biotechnology · DeepTech · Health
Size
1 - 10 employees
Stage
Other
founded in
2007
Promentis Pharmaceuticals, Inc. is a privately-held biopharmaceutical company focused on developing innovative therapies for neuropsychiatric disorders. Their lead compound, SXC-2023, targets trichotillomania, a prevalent disorder lacking FDA-approved treatments. The company aims to restore glutamatergic neurotransmission and address oxidative stress imbalances, which are key contributors to various CNS disorders. With a strong leadership team and a commitment to addressing significant patient needs, Promentis is positioned to make a meaningful impact in the biopharmaceutical industry.
Something looks off?Open jobs at Promentis Pharmaceuticals
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.